Methods and compositions for immunomodulation using CD1 antigens
US7253159B2 · kind B2 · utility
0Cited by
6References
32Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Apr 19, 2004 |
| Grant date | Aug 7, 2007 |
| Priority date | — |
| Expiry date | May 21, 2024 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/70596
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to novel CD1a-presented antigens. These antigens can be used as antigens, adjuvants or as immunomodulatory agents in a variety of diagnostic, therapeutic and prophylactic applications.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.